Aseptic meningitis in Fabry disease due to a novel GLA variant: an expanded phenotype?-Reference-Cited by-同舟云学术

Aseptic meningitis in Fabry disease due to a novel GLA variant: an expanded phenotype?

Published:2022-09-12 Issue:1 Volume:44 Page:319-327
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Nóbrega Paulo Ribeiro,Morais João Lucas Araújo,Ferreira Alliane Milliane,de Medeiros Alisson Dantas,Duarte Beatrice Araújo,Rangel Deborah Moreira,Lima Fabrício Oliveira,de Paiva Anderson Rodrigues Brandão,Paim-Marques Luciana,Kok Fernando,Pessoa André Luiz Santos,Braga-Neto Pedro^ORCID,Carvalho Fernanda Martins Maia

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-022-06388-y.pdf

Reference44 articles.

1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276(21):1163–1167. https://doi.org/10.1056/NEJM196705252762101

2. Sweeley CC, Klionsky B (1963) Fabry’s disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238:3148–3150

3. Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JM, Hollak CE (2006) Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis. 29(1):106–11. https://doi.org/10.1007/s10545-006-0196-0

4. Sestito S, Ceravolo F, Concolino D (2013) Anderson-Fabry disease in children. Curr Pharm Des 19(33):6037–6045. https://doi.org/10.2174/13816128113199990345

5. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281(3):249–254. https://doi.org/10.1001/jama.281.3.249

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Prevalence of Nonsense Pathogenic DMD Variants in a Single-Center Cohort from Brazil: A Genetic Profile Study That May Guide the Choice of Disease-Modifying Treatments;Brain Sciences;2023-10-28